Navigation Links
Endocare to Present at 2nd Annual OneMedForum
Date:1/7/2009

IRVINE, Calif., Jan. 7 /PRNewswire-FirstCall/ -- Endocare, Inc. (Nasdaq: ENDO), an innovative medical device company focused on the development of minimally invasive technologies for tissue and tumor ablation, today announced that management is scheduled to make an investor presentation at the 2nd Annual OneMedForum at 11:00 a.m. PT on Tuesday, January 13, 2009. The conference is being held at the Sir Francis Drake hotel January 13-14 in San Francisco.

A live webcast of the presentation at the conference will be available via a link provided at http://ir.endocare.com/events.cfm. An archived replay of the presentation will be available shortly after the presentation time for a period of 30 days. Web participants are encouraged to go to Endocare's website (http://ir.endocare.com/events.cfm) at least 15 minutes prior to the start of the call to register, download and install any necessary audio software.

Hosted by OneMedPlace, OneMedForum is a finance conference for emerging medtech companies. OneMedPlace (http://www.onemedplace.com) is a virtual community of healthcare and life science companies. It has, for the first time, put in place the innovations that will shape the future of health and medicine--emerging companies and technologies seeking capital, distribution, visibility and resources to help finance, build and grow, and investors and strategic partners looking for health and medical innovations to invest in, acquire, license, distribute, purchase or utilize.

About Endocare

Endocare, Inc. - www.endocare.com - is an innovative medical device company providing minimally invasive technologies for tissue and tumor ablation. Endocare has initially concentrated on developing technologies for the treatment of prostate cancer and believes that its proprietary technologies have broad applications across a number of markets, including the ablation of tumors in the kidney, lung and liver and palliative intervention (treatment of pain associated with metastases).

    Investor Contact:
    Matt Clawson
    Allen & Caron, Inc.
    (949) 474-4300
    matt@allencaron.com
    www.allencaron.com

    Media Contact:
    Len Hall
    Allen & Caron, Inc.
    (949) 474-4300
    len@allencaron.com
    www.allencaron.com

    For Additional Information:
    Terrence A. Noonan, Interim CEO
    Michael R. Rodriguez, CFO
    Endocare, Inc.
    (949) 450-5400
    www.endocare.com


'/>"/>
SOURCE Endocare, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Endocare and Galil Medical Sign Definitive Merger Agreement
2. Endocare to Present at Oppenheimer 19th Annual Healthcare Conference
3. Endocare and Former CFO Agree to Terminate Indemnification Agreement
4. Endocare Comments on Unsolicited Proposal
5. Endocare Reports Financial Results for Second Quarter 2008
6. Endocare to Present at the B. Riley & Co. 9th Annual Las Vegas Investor Conference
7. Endocare Reports 2007 Annual and Fourth Quarter Financial Results
8. Endocare Announces That National Cancer Institute to Sponsor Study Comparing Cryoablation to Radiation Therapy for Pain Relief in Bone Cancer Patients
9. Endocare Reports 2007 Third Quarter and Nine-Month Results
10. Endocare Stock to Commence Trading on NASDAQ
11. Gen-Probe to Webcast Presentation at the 27th Annual J.P. Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... February 24, 2017 , ... Indiana Fiber Network (IFN) President and CEO ... year. Dyer started as the Chairman of the Management Committee when IFN was ... corporation including the recruitment of investor/owners and development of the business plan. He ...
(Date:2/23/2017)... ... 2017 , ... Thinksport, the most award-winning sunscreen on the ... Marin. For the second year in a row, cyclists will stay protected from ... thrilled to provide our safe, non-toxic sunscreen to over 2,000 cycling enthusiasts again ...
(Date:2/23/2017)... ... February 23, 2017 , ... The American Cleft Palate-Craniofacial ... 74th Annual Meeting. KLS is a longtime supporter of the event. , "We ... and Platinum Sponsor," said Dr. Bob Havlik, 2017 ACPA President. "KLS Martin has a ...
(Date:2/23/2017)... ... February 23, 2017 , ... On April 13, 2017, ... “Doping in Sport: How the Culture Might Change,” in conjunction with ... symposium will be held at Pepperdine University in Malibu, California. , Sir Philip ...
(Date:2/23/2017)... NJ (PRWEB) , ... February 23, 2017 , ... ... the pre-eminent publication and community for those in the fight against cancer, has ... important in their success. HRA will release top-line findings in a webinar, ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)...  Xynomic Pharmaceuticals, Inc., an oncology drug research ... acquired exclusive worldwide rights to develop, manufacture and ... targeting hematological and solid tumors. To ... 2 clinical trials of Abexinostat in US, EU ... been completed, demonstrating that Abexinostat is clinically active ...
(Date:2/23/2017)... LG Innotek hat heute die weltweit erste ... das 1,5-fache des 45-mW-Moduls der Konkurrenz. UV-C ... und 280 nm und eignet sich damit für Sterilisationsaufgaben. Es ... zerstört. Das Produkt von LG Innotek erzeugt UV-Strahlung im ... ...
(Date:2/23/2017)... 2017 Im Rahmen seiner Schlüsselwachstumsstrategie arbeitet ... der südwestlichen chinesischen Provinz Guizhou, 2017 mit dem Angebot von ... an der Entwicklung einer eingebetteten Hightech-Schlüsselindustrie. Foto - ... ... ...
Breaking Medicine Technology: